Pancreatic Cancer Research

ResearcherWellcome Sanger InstituteActive in the last 2 years

Thomas Knösel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1822-0197; OpenAlex author ID A5071064116. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
96
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: 2 papers · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper

Papers 14

  1. Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. Co-author DOI 10.1158/0008-5472.can-23-3419↗
  2. Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144. Co-author DOI 10.1007/s00432-022-04518-9↗
  3. GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/gutjnl-2021-325803↗
  4. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003143↗
  5. Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites. Co-author DOI 10.1016/j.ebiom.2019.01.037↗
  6. Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00432-018-2717-2↗
  7. Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma. Co-author DOI 10.1186/s12885-018-4973-6↗
  8. Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00432-017-2351-4↗
  9. The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation. Co-author DOI 10.1371/journal.pone.0170390↗
  10. Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma. Last author DOI 10.1038/bjc.2015.362↗
  11. A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer. Co-author DOI 10.1038/ng.3164↗
  12. STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/gm526↗
  13. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/nature11114↗
  14. Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma. Last author DOI 10.1136/jclinpath-2011-200099↗

Closest collaborators

The 25 strongest of 96 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christian P. Pilarsky · 8 shared papers, 2012–2024 · strength 0.59
  2. Christiane J. Bruns · 5 shared papers, 2015–2023 · strength 0.46
  3. Ioannis Pozios · 4 shared papers, 2017–2023 · strength 0.40
  4. Hendrik Seeliger · 4 shared papers, 2017–2023 · strength 0.40
  5. Robert Grützmann · 5 shared papers, 2012–2024 · strength 0.35
  6. Albrecht Neeße · 2 shared papers, 2019–2024 · strength 0.24
  7. Yue Zhao · 3 shared papers, 2017–2018 · strength 0.23
  8. Pedro Antonio Pérez-Mancera · 3 shared papers, 2012–2024 · strength 0.21
  9. David Arthur Tuveson · 2 shared papers, 2012–2024 · strength 0.18
  10. Katharina Beyer · 1 shared paper, 2023 · strength 0.18
  11. Nina A. Hering · 1 shared paper, 2023 · strength 0.18
  12. Georgios Antonios Margonis · 1 shared paper, 2023 · strength 0.18
  13. Giuseppina Caligiuri · 1 shared paper, 2024 · strength 0.16
  14. Joaquín Araos Henríquez · 1 shared paper, 2024 · strength 0.16
  15. Camino Bermejo‐Rodríguez · 1 shared paper, 2024 · strength 0.16
  16. Lawrence N. Barrera · 1 shared paper, 2024 · strength 0.16
  17. Youngkyu Park · 1 shared paper, 2024 · strength 0.16
  18. Daniel Öhlund · 1 shared paper, 2024 · strength 0.16
  19. Giulia Biffi · 1 shared paper, 2024 · strength 0.16
  20. Wilko Weichert · 1 shared paper, 2023 · strength 0.13
  21. Sladjana Zagorac · 1 shared paper, 2023 · strength 0.13
  22. Anna Melissa Schlitter · 1 shared paper, 2023 · strength 0.13
  23. Irene Felipe‐Abrio · 1 shared paper, 2023 · strength 0.13
  24. Paula Ghaneh · 1 shared paper, 2023 · strength 0.13
  25. Daniel H. Palmer · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.